These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31954003)

  • 1. Detection of Campylobacter species in stool specimens from patients with symptoms of acute flaccid paralysis in South Africa.
    Thobela MS; Smith AM; Moonsamy S; Du Plessis H; Govender N; Keddy KH
    J Infect Dev Ctries; 2018 Jul; 12(7):542-549. PubMed ID: 31954003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Campylobacter species and Guillain-Barré syndrome.
    Nachamkin I; Allos BM; Ho T
    Clin Microbiol Rev; 1998 Jul; 11(3):555-67. PubMed ID: 9665983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
    Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome subtypes related to Campylobacter infection.
    Drenthen J; Yuki N; Meulstee J; Maathuis EM; van Doorn PA; Visser GH; Blok JH; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):300-5. PubMed ID: 21270063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Campylobacter infection and Guillain-Barré syndrome.
    Allos BM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain Barre syndrome: the leading cause of acute flaccid paralysis in Hazara division.
    Anis-ur-Rehman ; Idris M; Elahi M; Jamshed ; Arif A
    J Ayub Med Coll Abbottabad; 2007; 19(1):26-8. PubMed ID: 17867475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifteen years of acute flaccid paralysis surveillance in Hong Kong: findings from 1997 to 2011.
    National Committee for the Certification of Wild Poliovirus Eradication in Hong Kong
    J Paediatr Child Health; 2014 Jul; 50(7):545-52. PubMed ID: 24528511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological Markers of Recent
    Souza CO; Vieira MACS; Batista FMA; Eulálio KD; Neves JMM; Sá LC; Monteiro LCR; Almeida-Neto WS; Azevedo RSS; Costa DL; Cruz ACR
    Am J Trop Med Hyg; 2018 Feb; 98(2):586-588. PubMed ID: 29313470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Campylobacter jejuni/C.coli infection in patients with Guillain-Barré syndrome by serology and culture.
    Hariharan H; Naseema K; Kumaran C; Shanmugam J; Nair MD; Radhakrishnan K
    New Microbiol; 1996 Jul; 19(3):267-71. PubMed ID: 8841044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious causes of acute flaccid paralysis.
    Solomon T; Willison H
    Curr Opin Infect Dis; 2003 Oct; 16(5):375-81. PubMed ID: 14501988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
    Takahashi M; Koga M; Yokoyama K; Yuki N
    J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.
    Lastovica AJ; Goddard EA; Argent AC
    J Infect Dis; 1997 Dec; 176 Suppl 2():S139-43. PubMed ID: 9396698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome post renal transplant: A systematic review.
    Ostman C; Chacko B
    Transpl Infect Dis; 2019 Feb; 21(1):e13021. PubMed ID: 30403433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
    Koga M; Yuki N; Takahashi M; Saito K; Hirata K
    J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal limb weakness phenotype of Guillain-Barré syndrome.
    Koga M; Kishi M; Fukusako T; Kanda T
    J Neurol Sci; 2018 Sep; 392():83-88. PubMed ID: 30031173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain-Barré syndrome.
    Kokubun N; Shahrizaila N; Koga M; Hirata K; Yuki N
    Clin Neurophysiol; 2013 Aug; 124(8):1671-9. PubMed ID: 23514735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
    Ebrahim Soltani Z; Rahmani F; Rezaei N
    Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.